Opdivo (Yervoy) (nivolumab (ipilimumab))
pCPA File Number: 21427
Under consideration for negotiation
First-line treatment of patients with metastatic or recurrent non-small cell lung cancer (NSCLC)
Bristol Myers Squibb Canada Inc.
CADTH Project Number:
pCPA Engagement Letter Issued:
Negotiation Process Concluded: